Skip over main navigation
  • Sign up
  • Log in
  • Basket: (0 items)
Solving Kids' Cancer
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
Shop Contact us Donate
Menu
  • About us
    • What we do
    • Meet the team
      • Trustees
      • Our team
    • Patron
    • Join our Team
    • Annual reports
  • About neuroblastoma
    • What is neuroblastoma?
    • Symptoms
    • Diagnosis
    • Neuroblastoma treatment
  • Support
    • Family support
    • Access treatment
    • Neuroblastoma Parent Education Conference
      • Neuroblastoma Parent Global Symposium 2020
      • See past conferences
    • Other sources of help
  • Research
    • Our research
    • Scientific Advisory Board
    • Funding award process
    • Projects
    • Funding partners
    • Research policies
    • Research blog
  • Support Our Work
    • Christmas Corner
    • Donate now
    • Shop
    • Ambassador Programme
    • Corporate partnerships
    • Challenge events
    • Set up a fundraising page
    • Fundraising resources
  • Children’s stories
    • Stories
    • Children’s campaigns
    • In memory
    • Named funds
  • News
    • News
    • Blogs
  • Admin
    • Log in
  • Basket: (0 items)

What is neuroblastoma?

Neuroblastoma is a rare and aggressive childhood cancer that affects around 100 children each year in the UK. Most children are under the age of five.

Where in the body does neuroblastoma start?

Neuroblastoma is a cancer of the sympathetic nervous system, with tumours often occurring in the adrenal glands or abdomen.

Does neuroblastoma spread?

Half of all neuroblastoma cases are classified as ‘high-risk’, where the cancer has spread by the time it is diagnosed, and immediate treatment is required. Children diagnosed with high-risk neuroblastoma have about a 40-50% chance of long-term survival. It has one of the lowest survival rates of any childhood cancer and the causes are not known.  

Read more information on the stages of neuroblastoma.

What treatment is there for neuroblastoma?

Due to the nature of neuroblastoma, treatment can be intensive and can include chemotherapy, surgery, radiotherapy, stem cell treatment and immunotherapy. Read more information on neuroblastoma treatment.

40-50% of children diagnosed with high-risk neuroblastoma will not respond completely (this is known as refractory) during standard treatment, or the cancer will come back (this is known as relapse) after. If a child does relapse with neuroblastoma, their chances of long-term survival are less than 10%.

MYCN

Another important factor is the presence of the MYCN oncogene, which is found in around 30% of patients and is strongly associated with a poor prognosis. 

ALK - mutated ALK genes

Anaplastic Lymphoma Kinase (ALK) is a gene that tells your body how to make proteins that help cells talk to each other. Having mutated ALK genes is often indicative of a lower prognosis but the third-generation ALK inhibitor Lorlatinib trial is available for those deemed eligible.

Neuroblastoma progress

Despite progress in the treatment and understanding of neuroblastoma, survival rates – particularly when it comes to high-risk neuroblastoma – are still unacceptable. 

It’s essential that promising developments in research are translated into effective treatment interventions that not only save lives but also offer the maximum quality of life after cancer. Solving Kids’ Cancer is working to initiate and fund innovative neuroblastoma research.

Published: 4th July, 2019

Updated: 20th August, 2019

Author: Nick Pryce

Share this page
  • Email
  • Facebook
  • Twitter

Latest

  • Rocky’s 30hr Challenge for Nellie-Rose

    Rocky’s 30hr Challenge for Nellie-Rose

    Support me on my 30 hour challenge at Crayford Weights to raise money for the brave, brilliant and beautiful Nellie-Rose.

    I’m setting this at an ambitious £30,000 for 30 hours. Help me to get there!

  • Charity 24hr live stream for henry's appeal

    Charity 24hr live stream for henry's appeal

    I used to do 48 hr charity live streams in the 1st lockdown in the UK I am doing this to help a young boy in need

  • Kingfisher Flock’s Christmas Bonanza!

    Kingfisher Flock’s Christmas Bonanza!

    Kingfisher Flock’s Christmas Bonanza! Socially distanced Christmas entertainment, games and activities, and meeting Santa! Bringing together the Esland community homes all in aid of Ollie!

  • Kingfisher flock Santa’s grotto for Ollie

    Kingfisher flock Santa’s grotto for Ollie

Most read

  • Lily-Mae, Ireland’s Tiny Dancer, supports Solving Kids’ Cancer

    Lily-Mae, Ireland’s Tiny Dancer, supports Solving Kids’ Cancer

    Lily-Mae from Galway, Ireland will be celebrating her 12th birthday this April, but for her parents Judith and Leighton every day is a blessing.

  • Corey is thriving after neuroblastoma battle

    Corey is thriving after neuroblastoma battle

    Family donate almost £150,000 to neuroblastoma research

  • Solving Kids' Cancer welcomes Alexandra Lane to the Board of Trustees

    Solving Kids' Cancer welcomes Alexandra Lane to the Board of Trustees

    Alexandra Lane was formally voted on and welcomed to our Board of Trustees this week. We are thrilled to welcome Alex to the team.

  • BEACON study opens in Europe

    BEACON study opens in Europe

    The much-anticipated BEACON study amendment is now open and recruiting patients.

  • Steve Richards to step down as Chief Executive

    Steve Richards to step down as Chief Executive

    CEO to leave Solving Kids' Cancer after three years in the role.

  • Solving Kids’ Cancer appoints new Chief Executive Officer

    Solving Kids’ Cancer appoints new Chief Executive Officer

    Solving Kids’ Cancer, a national neuroblastoma charity, has appointed Gail Jackson as its new Chief Executive Officer.

  • Charities fund new clinical trial

    Charities fund new clinical trial

    Solving Kids’ Cancer, with Neuroblastoma UK, has awarded a grant of £609,762.40 to enable the SIOPEN High-Risk Neuroblastoma Clinical Trial 2 (HR-NBL2) to open in the UK, it is anticipated to open in early 2021.

  • First Three Months

    First Three Months

    Gail Jackson, CEO, launches her blog. Reflecting on personal resilience, our work and joining Solving Kids' Cancer as COVID hit.

  • Ewen's Appeal

    Ewen's Appeal

    Ewen is a happy and restless boy who runs everywhere. He loves trucks, cars and blowing dandelions. But this amazing little boy has had his childhood interrupted by childhood cancer.

  • Celebrating Success and Acknowledging Challenge

    Celebrating Success and Acknowledging Challenge

    Our CEO, Gail, reflects on 'Pandemic Fatigue' and the importance of celebrating success in the face of challenge.

Sign up for our newsletter

Please enter your first name
Please enter your last name
Please enter your email address Please enter a valid email address (e.g. [email protected])

Contact us

Solving Kids' Cancer UK
Coram Campus
41 Brunswick Square
London
WC1N 1AZ

Phone: 020 7284 0800

Follow us

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn

  • Jobs
  • Media enquiries
  • Sitemap
  • Accessibility
  • Terms & Conditions
  • Safeguarding Statement
  • Privacy Policy

Solving Kids’ Cancer UK is a registered charity in England and Wales (1135601), and in Scotland (SCO45094). It is a company limited by guarantee in England and Wales (7208648). The charity and company is currently operating as Solving Kids’ Cancer.